Eaton Vance Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.03M Buy
2022
Q2
$1.68M Buy
2022
Q1
$1.28M Buy
2021
Q4
$30K Hold
2021
Q3
$0 Buy
2021
Q2
Sell
2021
Q1
$137K Buy
2019
Q3
Sell
2019
Q2
$20.4M Buy
2019
Q1
$16M Buy
2018
Q4
$12.2M Buy